ClinicalTrials.gov
public full text
Public Domain
A Clinical Research of CAR T Cells Targeting CEA Positive Colorectal Cancer (CRC)
The main purpose of this research is to verify the safety of CEA targeted chimeric antigen receptor T cells and to determine the proper dosage of CAR T cells infused.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Study of CEA Targeting CAR-T (PTC13) in the Treatment of CEA-Positive Advanced Malignant Solid Tumors#865069
- Functional analysis of Ia-antigen positive T cells from normal adults#70402
- Human CD1c-autoreactive T cells recognise <i>Mycobacterium tuberculosis</i> –infected antigen-presenting cells and display cytotoxic effector programmes#273220
- AFP Specific T Cell Receptor Transduced T Cells Injection(C-TCR055) in Unresectable Hepatocellular Carcinoma#1075727
- Anti-CD19 Chimeric Antigen Receptor T Cells for Refractory Autoimmune Diseases#1152826
Record · ID 801249
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive